Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary surfactant biology in ventilated children with acute hypoxic respiratory failure (SARPS)
2010-023668-42Phase 4Unknown
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Poractant alfa in Acute hypoxaemic respiratory failure (AHRF) and sepsis, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoints: Rate of surfactant synthesis and Feasibility of choline chloride (trimethyl-D9) tracer. Status: unknown.
02
Drugs
Poractant alfa
03
Conditions
Acute hypoxaemic respiratory failure (AHRF)sepsis
Beyond the preview
Go deeper on 2010-023668-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023668-42.